u/liv_okafor

What did system suitability look like on that sequence?

That is area percent, not mass percent. The trace cannot give you the second one.

Careful — that is a question for whoever ordered the panel, and nobody in this thread can answer it responsibly.

Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.

holding a dose an extra month is a legitimate answer to bad tolerance

Same view — ApoB if you add one thing. It answers a question the standard panel only gestures at.

constipation on day two and gone by day four is the standard shape

Disagree. Severe abdominal pain is not on the list of things to wait out, and this board should not be treating it as one.

Did you run a blank between injections?

Small fix — that is a reconstructed entry rather than a contemporaneous one, and the post presents it as the latter.

Reflux was the one that got me.

Disagreeing with this one line: that symptom is not on the wait-and-see list and should not be posted as though it is.

Right, and weight loss itself moves several markers, so attribution is harder than these threads assume.

Adding the obvious one — take it to whoever ordered the panel. This board cannot read it for you.

Correction: that is a known effect of reduced intake rather than a direct drug effect. The distinction matters because the fix is different.

Bought a second-hand instrument and learned more in six months of fixing it than in three years of reading traces.

Cosigning the wavelength point. Half the disagreements in this board are two people looking at different detectors.

baseline before you start is worth more than any later panel

bring the numbers to someone qualified to read them

A log is only interpretable if the conditions are consistent. Same day, same time, same state, same scale — otherwise you are recording measurement variability rather than change.

write down when it starts and stops, the pattern is the useful part

baseline before you start is worth more than any later panel

Is that baseline drawn by the software or by hand?

Same method at both labs, or two different gradients?

assay method matters, especially between different labs

ask whether the lab changed its assay between your two draws

Yes. Repeat before you react. Almost every alarming single value I have posted here regressed on the repeat.

report the method or do not report the number

Adding one practical thing — run the blank. It answers this before anyone has to argue about it.

Right, and the hair thing is worth repeating: it tracks the rate of loss rather than the compound, and it stops.

integration decisions move the number more than the sample does

That is a non-fasting value and the interval you are comparing it against is a fasting one.

Have you taken this to whoever ordered it?

Is that the same assay, or did the lab change platforms?

What is the one column you added late and wish you had from the start?

That template is elaborate enough that you will stop using it by week ten. Mine was.

axis labels or the trace is decoration

Do you have the mass, or only the UV trace?

lab reference ranges are not treatment targets

Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.